These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12758239)

  • 1. Radiotherapy and chemotherapy with or without carbogen and nicotinamide in inoperable biopsy-proven glioblastoma multiforme.
    Simon JM; Noël G; Chiras J; Hoang-Xuan K; Delattre JY; Baillet F; Mazeron JJ
    Radiother Oncol; 2003 Apr; 67(1):45-51. PubMed ID: 12758239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatment.
    Fatigante L; Ducci F; Cartei F; Colosimo S; Marini C; Prediletto R; Danesi R; Laddaga M; Del Tacca M; Caciagli P
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):499-504. PubMed ID: 9112444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.
    Miralbell R; Mornex F; Greiner R; Bolla M; Storme G; Hulshof M; Bernier J; Denekamp J; Rojas AM; Pierart M; van Glabbeke M; Mirimanoff RO
    J Clin Oncol; 1999 Oct; 17(10):3143-9. PubMed ID: 10506611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance of nicotinamide and carbogen with radiation therapy for glioblastoma.
    Pickles T; Graham P; Syndikus I; Rheaume DE; Duncan GG; Green A; Marlow C
    Radiother Oncol; 1996 Sep; 40(3):245-7. PubMed ID: 8940752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionated irradiation combined with carbogen breathing and nicotinamide of two human glioblastomas grafted in nude mice.
    Sun LQ; Coucke PA; Mirimanoff RO; Buchegger F
    Radiat Res; 2001 Jan; 155(1 Pt 1):26-31. PubMed ID: 11121212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.
    Hoskin PJ; Saunders MI; Phillips H; Cladd H; Powell ME; Goodchild K; Stratford MR; Rojas A
    Br J Cancer; 1997; 76(2):260-3. PubMed ID: 9231929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.
    Kaanders JH; Pop LA; Marres HA; Liefers J; van den Hoogen FJ; van Daal WA; van der Kogel AJ
    Radiother Oncol; 1998 Aug; 48(2):115-22. PubMed ID: 9783882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short communication: the addition of carbogen and nicotinamide to a palliative fractionation schedule for locally advanced breast cancer.
    Pigott K; Dische S; Saunders MI
    Br J Radiol; 1995 Feb; 68(806):215-8. PubMed ID: 7537598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) in high grade malignant gliomas.
    Lambin P; Poortmans P; Menten J; Hamers HP
    Radiother Oncol; 1997 Jun; 43(3):324. PubMed ID: 9215796
    [No Abstract]   [Full Text] [Related]  

  • 10. Carbogen breathing in patients with glioblastoma multiforme submitted to radiotherapy. Assessment of gas exchange parameters.
    Fatigante L; Cartei F; Ducci F; Marini C; Prediletto R; Caciagli P; Laddaga M
    Acta Oncol; 1994; 33(7):807-11. PubMed ID: 7993650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of perfusion enhancement after administration of nicotinamide and carbogen in patients with glioblastoma: a 99mTc-HMPAO SPECT study.
    Hulshof MC; Rehmann CJ; Booij J; van Royen EA; Bosch DA; González González D
    Radiother Oncol; 1998 Aug; 48(2):135-42. PubMed ID: 9783884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).
    Bernier J; Denekamp J; Rojas A; Minatel E; Horiot J; Hamers H; Antognoni P; Dahl O; Richaud P; van Glabbeke M; Piérart M
    Radiother Oncol; 2000 May; 55(2):111-9. PubMed ID: 10799722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
    Ono K; Masunaga S; Akuta K; Akaboshi M; Abe M
    Radiother Oncol; 1993 Aug; 28(2):162-7. PubMed ID: 8248558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.
    Stüben G; Stuschke M; Knühmann K; Horsman MR; Sack H
    Radiother Oncol; 1998 Aug; 48(2):143-8. PubMed ID: 9783885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide.
    Bussink J; Kaanders JH; Van der Kogel AJ
    Acta Oncol; 1999; 38(7):875-82. PubMed ID: 10606417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
    Rojas A; Vojnovic B; Johns H; Joiner MC; Martindale C; Fowler JF; Denekamp J
    Radiother Oncol; 1996 Apr; 39(1):53-64. PubMed ID: 8735494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ; Horsman MR; Siemann DW
    Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity.
    Kaanders JH; Pop LA; Marres HA; van der Maazen RW; van der Kogel AJ; van Daal WA
    Radiother Oncol; 1995 Dec; 37(3):190-8. PubMed ID: 8746587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ; Menke D; Brown JM
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.